FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to fluorinated catharantine derivatives of general formula I 
in which broken line represents possibility of double bond presence, when substitution X is absent, or simple bond, when X stands for substitution with another group: H, R1, R2 and R3 independent on each other represent a fluorine atom or methylated group, and n=2.
EFFECT: invention also relates to method of obtaining said derivative and to its application as intermediate compound for synthesis of fluorated dimeric Vinca alkaloids, in particular vinflunine, which in its turn is used as anti-cancer agent.
22 cl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREPARING COMPOUNDS, COMPOSITION FOR PREPARING MEDICINAL AGENT | 2001 |
|
RU2290409C2 |
| METHODS OF SYNTHESIS OF ESTEINASCIDINE, COMPOUNDS, INTERMEDIATE SUBSTANCE | 1997 |
|
RU2194709C2 |
| PYRAZOLOPYRIMIDINE DERIVATIVES AS CYCLIN-DEPENDENT KINASE INHIBITORS | 2005 |
|
RU2414472C9 |
| ENANTIOSELECTIVE SYNTHESIS OF DERIVATIVES OF GAMMA-AMINO-ALPHA, BETA-UNSATURATED CARBOXYLIC ACIDS | 2009 |
|
RU2512499C2 |
| BENZYLPHENYLCYCLOHEXANE DERIVATIVES AND METHODS OF THEREOF APPLICATION | 2008 |
|
RU2505521C2 |
| NOVEL COMPOUNDS OF CONDENSED IMIDAZOLE POSSESSING OF CB2 RECEPTOR AGONIST PROPERTY | 2002 |
|
RU2312864C2 |
| CASPASE INHIBITORS | 1999 |
|
RU2274642C2 |
| NEW HEM-DIFLUORIDATED COMPOUNDS, METHODS OF THEIR PRODUCING AND THEIR APPLICATION | 2003 |
|
RU2369612C2 |
| HETEROCYCLIC MUSCARINIC AGONISTS AND COMPOSITIONS, THEIR USING AND METHODS FOR TREATMENT | 2002 |
|
RU2292346C2 |
| ERBB/BTK INHIBITORS | 2019 |
|
RU2764069C1 |
